Transdermal Delivery of Bioidentical Progesterone with a Steroid 5α-Reductase Inhibitor (Dutasteride): a Pilot Study

Transdermal Delivery of Bioidentical Progesterone with a Steroid 5α-Reductase Inhibitor (Dutasteride): a Pilot Study

Purpose: Bioavailability of transdermal progesterone is low and variable. This may be attributed to transdermal metabolism by the 5α-reductase enzymes or the direct transport to the saliva. The objective of the current study was to evaluate the effect of enzyme inhibition on the bioavailability of t...

Full description

Bibliographic Details
Main Authors:	sara Zargar-Shoshtari, Hannaneh Wahhabaghei, Abdolrasoul Mehrsai, Jingyuan Wen, Raid Alany
Format:	Article
Language:	English
Published:	Canadian Society for Pharmaceutical Sciences 2011-01-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/9065

Similar Items

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
by: Tina Kiguradze, et al.
Published: (2017-03-01)

The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
by: Alexander B. Opoku-Acheampong, et al.
Published: (2017-07-01)

Steroid Hormone Receptors as Potential Mediators of the Clinical Effects of Dutasteride
by: João C. C. Alonso MD, et al.
Published: (2017-01-01)

Defining bioidentical hormones for menopause-related symptoms
by: Whelan AM, et al.
Published: (2011-03-01)

Influence of monoolein on progesterone transdermal delivery
by: Wanessa de Souza Cardoso Quintão, et al.
Published: (2015-12-01)

Bioidentical hormone therapy: Nova Scotia pharmacists’ knowledge and beliefs
by: Whelan AM, et al.
Published: (2012-09-01)

Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study
by: Daniels Kelly R, et al.
Published: (2011-06-01)

Use of dutasteride in carcinoma prostate
by: R P Shrinivas
Published: (2014-01-01)

Biopsiquiatria e bioidentidade: política da subjetividade contemporânea Biopsychiatry and bioidentity: politics of subjectivity nowadays
by: Anderson Luiz Barbosa Martins
Published: (2008-12-01)

Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
by: Qingpin Xiao, et al.
Published: (2020-10-01)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
by: Joe Miller, et al.
Published: (2007-04-01)

Preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice.
by: Alexander B Opoku-Acheampong, et al.
Published: (2013-01-01)

Development and formulation for Dutasteride hard capsules dosage form
by: LIU,MING-SIAN, et al.
Published: (2016)

Behandling av androgen alopeci med 5α-reduktashämmarna finasterid och dutasterid samt dess biverkningar.
by: Engström, Viktor
Published: (2020)

Androgenic alopecia and dutasteride in hair mesotherapy: A short review
by: Estela B Busanello, et al.
Published: (2018-02-01)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
by: J Miller, et al.
Published: (2009-06-01)

Fixed-Dose Combination Formulation and Development of Tamsulosin Hydrochloride and Dutasteride
by: CHOU,MING-CHERNG, et al.
Published: (2016)

Response of prostate cancer to addition of dutasteride after progression on abiraterone
by: Jian-Po Lian, et al.
Published: (2021-01-01)

Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
by: Zexian Zeng, et al.
Published: (2018-01-01)

Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making
by: Jennifer Jo Thompson, et al.
Published: (2017-10-01)

Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making
by: Thompson, Jennifer Jo, et al.
Published: (2017)

The characterisation of the catalytic activity of human steroid 5α-reductase towards novel C19 substrates
by: Quanson, Jonathan Luke
Published: (2015)

Optimization of transdermal permeation of non-steroidal anti-inflammatory agents and sunscreens
by: Sarveiya, Vikram
Published: (2013)

Optimization of transdermal permeation of non-steroidal anti-inflammatory agents and sunscreens
by: Sarveiya, Vikram
Published: (2013)

THE EFFICACY OF DUTASTERIDE AND GREEN TEA TOWARDS BLEEDING ON BPH AFTER TURP: STUDY THEIR EFFECT ON HIF-1α EXPRESSION & HEMATOCRIT
by: Andry Irawan, et al.
Published: (2017-07-01)

Neuroactive Steroids in First-Episode Psychosis: A Role for Progesterone?
by: Martino Belvederi Murri, et al.
Published: (2016-01-01)

Controlled release of dutasteride from biodegradable microspheres: in vitro and in vivo studies.
by: Xiangyang Xie, et al.
Published: (2014-01-01)

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
by: Tony Antoniou, et al.
Published: (2018-05-01)

Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use
by: Maria Maddalena Sirufo, et al.
Published: (2021-04-01)

A pilot study of transdermal gabapentin in cats
by: Jennifer E. Slovak, et al.
Published: (2021-07-01)

A randomised pilot equivalence trial to evaluate diamagnetically enhanced transdermal delivery of key ground substance components in comparison to an established transdermal non-steroidal anti-inflammatory formulation in males with prior knee injury.
by: Bill Vicenzino, et al.
Published: (2019-01-01)

Molecular features of steroid-binding antidins and their use for assaying serum progesterone.
by: Nitin Agrawal, et al.
Published: (2019-01-01)

Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia.
by: Arang Rhie, et al.
Published: (2019-01-01)

Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS
by: Luca Cindolo, et al.
Published: (2013-12-01)

Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia
by: Bilal Chughtai, et al.
Published: (2012-10-01)

Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia
by: Konstantinos Dimitropoulos, et al.
Published: (2016-02-01)

Simultaneous estimation of dutasteride and tamsulosin hydrochloride in tablet dosage form by vierordt’s method
by: P. Giriraj, et al.
Published: (2017-05-01)

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
by: Gonzalo Villapalos-García, et al.
Published: (2021-10-01)

Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism
by: Yufei Han, et al.
Published: (2021-01-01)

Stability of Positively Charged Nanoemulsion Formulation Containing Steroidal Drug for Effective Transdermal Application
by: Stephanie Da Costa, et al.
Published: (2014-01-01)